Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):

May 4, 2004

 

 

MYRIAD GENETICS, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware   0-26642   87-0494517

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

320 Wakara Way

Salt Lake City, Utah 84108

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (801) 584-3600

 

 

(Former name or former address, if changed since last report)

 

Item 7. Financial Statements and Exhibits.

 

  (c) Exhibits.

 

99.1 Earnings release dated May 4, 2004 for the three and nine months ended March 31, 2004.

 

This earnings release is being furnished pursuant to Item 12 of this Current Report on Form 8-K and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

 

Item 12. Results of Operations and Financial Condition

 

On May 4, 2004, Myriad Genetics, Inc. announced its financial results for the three and nine months ended March 31, 2004. The earnings release is attached hereto as an exhibit to this current report on Form 8-K and is being furnished pursuant to this Item 12 as Exhibit 99.1 to this Current Report on Form 8-K.

 

Page 2 of 4 pages

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   

Myriad Genetics, Inc.

   

(Registrant)

Date: May 4, 2004

  

By:

  

/s/ Peter D. Meldrum

       

Peter D. Meldrum

       

President and Chief Executive Officer

 

Page 3 of 4 pages

EXHIBIT INDEX

 

Exhibit

Number

  

Description

99.1   Earnings release dated May 4, 2004 for the three and nine months ended March 31, 2004.

 

Page 4 of 4 pages